Vaccine and Infectious Disease Division
Three groups of VIDD researchers at Fred Hutchinson Cancer Research Center have received a total of $800,000 in grants to investigate approaches to overcoming the main barrier to an HIV cure: reducing reservoirs of virus that lie dormant in some of the longest-lived cells of the body.
All of the grants — announced on the same day last month — are from the New York-based American Foundation for AIDS Research, or amfAR, as part of its Countdown to a Cure initiative. Two of the grants, to Drs. Keith Jerome and Hans-Peter Kiem, respectively, will fund research in preclinical models on cell and gene therapies.
The third grant — to Drs. Josh Schiffer and Florian Hladik — will support a small human clinical trial to test whether a drug already approved for another purpose can shrink reservoirs of HIV.